Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,750 | -40,448 | -53,689 | 6,973 | -112,415 |
| Depreciation Amortization | 1,406 | 2,235 | 2,390 | 3,127 | 3,362 |
| Accounts receivable | N/A | N/A | -3,079 | -1,834 | 2,172 |
| Accounts payable and accrued liabilities | -702 | -2,697 | 1,279 | 195 | 2,479 |
| Other Working Capital | -2,406 | -2,191 | -3,251 | -4,496 | 13,630 |
| Other Operating Activity | -9,866 | 718 | 4,928 | -45,538 | 53,910 |
| Operating Cash Flow | $-29,318 | $-42,383 | $-51,422 | $-41,573 | $-36,862 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -88 | -153 | -976 | -1,402 | -2,512 |
| Net Acquisitions | 28,120 | 4,250 | 65 | 59,763 | N/A |
| Purchase Of Investment | N/A | N/A | -16,535 | -99,633 | -44,882 |
| Sale Of Investment | N/A | N/A | 90,243 | 70,730 | N/A |
| Investing Cash Flow | $28,032 | $4,097 | $72,797 | $29,458 | $-47,394 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 24,731 | N/A | N/A | N/A | 18,038 |
| Debt Repayment | -22,104 | -137 | N/A | N/A | N/A |
| Common Stock Issued | 21,258 | 20,344 | 623 | 442 | 38 |
| Other Financing Activity | -11 | -58 | -1,410 | 19,092 | 71,219 |
| Financing Cash Flow | $23,874 | $20,149 | $-787 | $19,534 | $89,295 |
| Beginning Cash Position | 19,946 | 38,083 | 17,495 | 10,076 | 4,637 |
| End Cash Position | 42,534 | 19,946 | 38,083 | 17,495 | 9,676 |
| Net Cash Flow | $22,588 | $-18,137 | $20,588 | $7,419 | $5,039 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,318 | -42,383 | -51,422 | -41,573 | -36,862 |
| Capital Expenditure | -88 | -153 | -976 | -1,402 | -2,512 |
| Free Cash Flow | -29,406 | -42,536 | -52,398 | -42,975 | -39,374 |